Clinical Trials Logo

Clinical Trial Summary

To compare the effect of restrictive versus liberal red blood cell transfusion thresholds on long-term neurodevelopmental outcome in extremely low birth weight infants.


Clinical Trial Description

Extremely low birth weight (ELBW) infants uniformly develop anemia of prematurity and frequently require multiple red blood cell transfusions (RBCT) during neonatal intensive care. The criteria currently applied to indicate RBCT in this population are based on expert opinion rather than evidence and conclusive data of long-term effects of RBCT practices do not exist. Both, giving RBCT to improve oxygen carrying capacity and restricting RBCT to avoid RBCT associated risks and costs potentially impair long-term development. The proposed blinded randomized controlled trial was designed and will be powered to compare the effect of restrictive versus liberal red blood cell transfusion guidelines on long-term neurodevelopmental outcome in ELBW infants. ELBW infants will be randomized to receive RBCT according to liberal or restrictive RBCT guidelines, which both reflect current practice in Germany and aim for a clinically relevant difference in mean hemoglobin concentrations. The primary outcome measure is the incidence of death or major neurodevelopmental impairment determined at 24 months of age corrected for prematurity. Key secondary outcomes are the incidences of individual components of the composite primary outcome, the mental and physical developmental index scores of the Bayley Scales of Infant Development (II edition), and growth. Safety analyses will assess the incidences of all major diseases of prematurity. The results of this trial may help to improve the quality of life of these patients and reduce long-term health care costs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01393496
Study type Interventional
Source University Hospital Tuebingen
Contact
Status Completed
Phase Phase 4
Start date July 2011
Completion date October 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT00167388 - The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants Phase 1
Completed NCT01735578 - Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis N/A
Recruiting NCT04497012 - Iron Supplementation and Intestinal Health Phase 4
Completed NCT01539356 - Hepcidin Levels in Preterm Infants N/A
Completed NCT02101086 - Autologous Cord Blood Transfusion in Preterm Infants N/A
Recruiting NCT04509375 - Near-Infrared Spectroscopy and Cranial Doppler in Premature Newborns With Anemia
Terminated NCT01735552 - Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates N/A
Completed NCT00458068 - Early Versus Late Enteral Iron in Infants Less Than 1301 Grams N/A
Not yet recruiting NCT06220461 - Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants N/A
Withdrawn NCT01121328 - Autologous Umbilical Cord Blood Transfusion for Preterm Neonates Phase 1
Completed NCT00182390 - Premature Infants in Need of Transfusion (PINT) Phase 3
Completed NCT00457990 - Neurodevelopment After Early Iron Supplementation N/A